I-4-Amino-3-Chlorophenol CAS 17609-80-2 iLenvatinib Mesylate Ucoceko oluPhakathi >99.0% (HPLC)

Inkcazelo emfutshane:

Igama leKhemikhali: 4-Amino-3-Chlorophenol

CAS: 17609-80-2

Ubunyulu: >99.0% (HPLC)

Imbonakalo: I-Brown Solid Powder

Umbindi weLenvatinib Mesylate CAS 857890-39-2

Qhagamshelana: UGqr. Alvin Huang

Iselula/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Iipropati zeMichiza:

Igama leMchiza 4-Amino-3-Chlorophenol
Izithethantonye 3-Chloro-4-Aminophenol;Lenvaint-G
Inombolo yeCAS 17609-80-2
Inombolo yeCAT RF-PI1968
Ubume beStokhwe Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli C6H6ClNO
Ubunzima beMolekyuli 143.57
Ukuxinana 1.406±0.060 g/cm3
Uphawu Ruifu Chemical

Iinkcukacha:

Into Iinkcukacha
Imbonakalo I-Brown Solid Powder
I-1 H NMR Spectrum Ukungqinelana Nolwakhiwo
Ukuchongwa-HPLC Ixesha lokugcinwa liyafana nomgangatho
Ubunyulu / Indlela yokuHlalutya >99.0% (HPLC)
Indawo yokunyibilika 138.0 ~ 141.0℃
Ilahleko ekomisweni <1.00%
Intsalela kwi-Ignition <0.30%
Ukungcola ngokupheleleyo <1.00%
Umgangatho woVavanyo Umgangatho woShishino
Ukusetyenziswa Umbindi weLenvatinib Mesylate (CAS: 857890-39-2)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

1

FAQ:

Isicelo:

I-4-Amino-3-Chlorophenol (i-CAS: i-17609-80-2) yinto ebalulekileyo ye-pharmaceutical intermediate, esetyenziswa ngokubanzi kwi-design and synthesis ye-anti-tumor, izifo ze-cardiovascular, izifo ze-neurological drugs.I-4-Amino-3-Chlorophenol yinto ebalulekileyo ephakathi ekulungiseleleni iLenvatinib Mesylate (CAS: 857890-39-2).Iphuhliswe yi-Eisai Inc., i-lenvatinib mesylate yi-vascular endothelial growth factor receptor (VEGF) inhibitor enomsebenzi ochasene ne-VEGF subtypes 1, 2, kunye ne-3 kwaye yamkelwa yi-FDA kwi-2015 yonyango lomhlaza we-thyroid owahlukileyo okhoyo ekuhlaleni. iphindaphinda, i-metastatic, okanye iqhubela phambili kwaye ayizange iphendule kunyango lwe-iodine ye-radioactive.NgoMeyi ka-2016, i-FDA yavuma ichiza njengonyango oludityanisiweyo kunye ne-everolimus kunyango lwe-advanced renal cell carcinoma.Ngenxa yokuba i-VEGF (kunye ne-fibroblast growth factor receptors, eyaziwa ngokuba yi-FGFRs) icingelwa ukuba idlala indima kwi-cardiovascular signaling pathways, i-VEGF2R kunye ne-FGFR inhibition kucingelwa ukuba ziinkqubo ezisemva kwesiphumo sokuqala se-lenvatinib mesylate, i-hypertension.

Bhala umyalezo wakho apha kwaye uwuthumele kuthi